Vanda Historical Cash Flow
| VNDA Stock | USD 4.69 0.09 1.96% |
Analysis of Vanda Pharmaceuticals cash flow over time is an excellent tool to project Vanda Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 69.4 M or Other Non Cash Items of 3.5 M as it is a great indicator of Vanda Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Vanda Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vanda Pharmaceuticals is a good buy for the upcoming year.
Vanda |
About Vanda Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Vanda balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Vanda's non-liquid assets can be easily converted into cash.
Vanda Pharmaceuticals Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Vanda Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Vanda Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Vanda Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Vanda Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vanda Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Vanda Stock refer to our How to Trade Vanda Stock guide.At present, Vanda Pharmaceuticals' Other Non Cash Items is projected to increase significantly based on the last few years of reporting. The current year's Change To Liabilities is expected to grow to about 14.2 M, whereas Change In Cash is projected to grow to (31.8 M).
Vanda Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Vanda Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vanda Pharmaceuticals cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 16.0M | (9.0M) | 82.9M | 792K | (33.5M) | (31.8M) | |
| Free Cash Flow | 50.0M | 63.7M | 31.3M | 12.4M | (16.2M) | (15.4M) | |
| Change In Working Capital | 4.3M | 2.7M | 6.1M | (747K) | (6.6M) | (6.2M) | |
| Begin Period Cash Flow | 45.7M | 61.6M | 52.6M | 135.5M | 136.3M | 69.4M | |
| Other Cashflows From Financing Activities | 5.6M | 3.6M | 734K | (12.1M) | (155K) | (147.3K) | |
| Depreciation | 2.9M | 2.8M | 2.7M | 3.0M | (6.1M) | (5.8M) | |
| Other Non Cash Items | 1.7M | 3.4M | (507K) | (4.7M) | 3.3M | 3.5M | |
| Capital Expenditures | 1.8M | 552K | 679K | 383K | 490K | 465.5K | |
| Total Cash From Operating Activities | 51.8M | 64.2M | 32.0M | 12.8M | (15.8M) | (15.0M) | |
| Change To Account Receivables | (3.8M) | (2.5M) | (1.1M) | (707K) | (13.0M) | (12.4M) | |
| Net Income | 23.3M | 33.2M | 6.3M | 2.5M | (18.9M) | (18.0M) | |
| Total Cash From Financing Activities | 5.6M | 3.6M | 734K | 605K | (155K) | (147.3K) | |
| End Period Cash Flow | 61.6M | 52.6M | 135.5M | 136.3M | 102.8M | 74.4M | |
| Change To Liabilities | 3.5M | 3.8M | 3.0M | 11.8M | 13.6M | 14.2M | |
| Stock Based Compensation | 13.4M | 15.4M | 16.3M | 14.0M | 12.4M | 11.8M | |
| Total Cashflows From Investing Activities | (68.3M) | (41.5M) | (76.7M) | 49.9M | 44.9M | 47.2M | |
| Change To Inventory | (2.9M) | (2.2M) | (4.5M) | (771K) | (29K) | (30.5K) | |
| Change To Netincome | (72.5M) | 21.3M | 23.8M | 19.9M | 22.8M | 24.0M | |
| Sale Purchase Of Stock | 6.3M | 5.6M | 3.6M | 734K | 844.1K | 801.9K | |
| Investments | (39.7M) | (76.1M) | 50.6M | 107.2M | (17.4M) | (16.6M) | |
| Change Receivables | 2.3M | (3.8M) | (2.5M) | (1.1M) | (980.1K) | (1.0M) | |
| Cash And Cash Equivalents Changes | (16.1M) | 15.9M | (8.9M) | 82.6M | 95.0M | 99.8M | |
| Cash Flows Other Operating | (2.0M) | 7.0M | 4.4M | (151K) | (135.9K) | (129.1K) | |
| Other Cashflows From Investing Activities | 229K | 12K | 50.6M | (4.2M) | (4.9M) | (5.1M) | |
| Change To Operating Activities | (2.0M) | 7.2M | 4.4M | (151K) | (135.9K) | (129.1K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vanda Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Vanda Stock refer to our How to Trade Vanda Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vanda Pharmaceuticals. If investors know Vanda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vanda Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (0.19) | Revenue Per Share | Quarterly Revenue Growth 0.228 | Return On Assets |
The market value of Vanda Pharmaceuticals is measured differently than its book value, which is the value of Vanda that is recorded on the company's balance sheet. Investors also form their own opinion of Vanda Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vanda Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vanda Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vanda Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vanda Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vanda Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vanda Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.